ATE319716T1 - Mikanolid-derivate, ihre herstellung und ihr gebrauch für therapeutische anwendungen - Google Patents

Mikanolid-derivate, ihre herstellung und ihr gebrauch für therapeutische anwendungen

Info

Publication number
ATE319716T1
ATE319716T1 AT02710969T AT02710969T ATE319716T1 AT E319716 T1 ATE319716 T1 AT E319716T1 AT 02710969 T AT02710969 T AT 02710969T AT 02710969 T AT02710969 T AT 02710969T AT E319716 T1 ATE319716 T1 AT E319716T1
Authority
AT
Austria
Prior art keywords
micanolide
derivatives
preparation
therapeutic applications
therapeutic
Prior art date
Application number
AT02710969T
Other languages
English (en)
Inventor
Olivier Lavergne
Christophe Lanco
Gregoire Prevost
Beng Poon Teng
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0100397A external-priority patent/FR2819513B1/fr
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Application granted granted Critical
Publication of ATE319716T1 publication Critical patent/ATE319716T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/18Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Urology & Nephrology (AREA)
  • Virology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT02710969T 2001-01-12 2002-01-11 Mikanolid-derivate, ihre herstellung und ihr gebrauch für therapeutische anwendungen ATE319716T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0100397A FR2819513B1 (fr) 2001-01-12 2001-01-12 Nouveaux derives du mikanolide, leur preparation et leurs applications therapeutiques
FR0114688 2001-11-14

Publications (1)

Publication Number Publication Date
ATE319716T1 true ATE319716T1 (de) 2006-03-15

Family

ID=26212826

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02710969T ATE319716T1 (de) 2001-01-12 2002-01-11 Mikanolid-derivate, ihre herstellung und ihr gebrauch für therapeutische anwendungen

Country Status (20)

Country Link
US (1) US6887869B2 (de)
EP (1) EP1353926B1 (de)
JP (1) JP4418627B2 (de)
KR (1) KR100859227B1 (de)
CN (1) CN1234711C (de)
AR (1) AR035681A1 (de)
AT (1) ATE319716T1 (de)
AU (1) AU2002229870B2 (de)
BR (1) BR0206311A (de)
CA (1) CA2433981A1 (de)
CZ (1) CZ20032167A3 (de)
DE (1) DE60209698T2 (de)
ES (1) ES2260417T3 (de)
MX (1) MXPA03006162A (de)
MY (1) MY130454A (de)
NZ (1) NZ526690A (de)
PL (1) PL365342A1 (de)
RU (1) RU2278121C2 (de)
TW (1) TWI293302B (de)
WO (1) WO2002055523A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7678904B2 (en) 2003-07-11 2010-03-16 University Of Kentucky Use of parthenolide derivatives as antileukemic and cytotoxic agents
EP1643984B1 (de) * 2003-07-11 2011-07-06 University of Kentucky Research Foundation Verwendung von parthenolid-derivaten als antileukämische und zytotoxische mittel
CN103004761B (zh) * 2012-12-27 2013-12-04 中山火炬职业技术学院 一种薇甘菊正丁醇提取物及其制备方法和用途
CN106719727A (zh) * 2016-12-13 2017-05-31 安徽东健化工科技有限公司 一种除虫剂
CN111484503B (zh) * 2020-01-10 2022-05-27 贵州省中国科学院天然产物化学重点实验室(贵州医科大学天然产物化学重点实验室) 一种薇甘菊内酯衍生物及其制备方法和应用
CN115918668B (zh) * 2022-12-13 2024-03-22 西南林业大学 倍半萜内酯作抗烟草花叶病毒药物的应用及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2801792B1 (fr) 1999-12-01 2003-04-18 Sod Conseils Rech Applic Un nouveau medicament, le dihydromikanolide, son obtention par extraction de la plante mikania micrantha et son utilisation comme agent anti-proliferatif

Also Published As

Publication number Publication date
RU2278121C2 (ru) 2006-06-20
WO2002055523A1 (fr) 2002-07-18
EP1353926B1 (de) 2006-03-08
RU2003124760A (ru) 2005-01-10
CN1484646A (zh) 2004-03-24
US20040122084A1 (en) 2004-06-24
DE60209698T2 (de) 2006-11-16
EP1353926A1 (de) 2003-10-22
JP4418627B2 (ja) 2010-02-17
ES2260417T3 (es) 2006-11-01
NZ526690A (en) 2005-02-25
PL365342A1 (en) 2004-12-27
JP2004520353A (ja) 2004-07-08
MY130454A (en) 2007-06-29
BR0206311A (pt) 2004-02-17
KR100859227B1 (ko) 2008-09-18
MXPA03006162A (es) 2003-09-16
US6887869B2 (en) 2005-05-03
CZ20032167A3 (en) 2004-05-12
CA2433981A1 (fr) 2002-07-18
DE60209698D1 (de) 2006-05-04
TWI293302B (en) 2008-02-11
CN1234711C (zh) 2006-01-04
AU2002229870B2 (en) 2006-07-13
KR20030066806A (ko) 2003-08-09
AR035681A1 (es) 2004-06-23

Similar Documents

Publication Publication Date Title
ATE472534T1 (de) Benzimidazolderivate: herstellung und pharmazeutische anwendungen
DE60203917D1 (de) Phenylsulfonyl-1,3-dihydro-2h-indol-2-on derivate, deren herstellung und deren therapeutische verwendung
ATE539062T1 (de) Bizyklishe verbindung, ihre herstellung und verwendung
DE60107859D1 (de) Benzimidazolderivate, ihre herstellung und therapeutische verwendung
ATE296302T1 (de) 4-(1,3,4-thiadiazolyl-2-yl)-1,4-diazabizyklo- 3.2.2 nonanderivate, ihre herstellung und ihre therapeutische verwendung
DE602004022946D1 (de) 4-cyanopyrazol-3-carbonsäureamidderivate, herstellung und therapeutische anwendung davon
EE200300544A (et) 4-anilinokinoliin-3-karboksamiidid, nende kasutamine ning valmistamine
ATE424202T1 (de) Substituierte 2-thio-3,5-dicyano-4-phenyl-6- aminopyridine und ihre verwendung
ECSP045081A (es) Derivados de 1,8-naftiridina y su uso para el tratamiento de la diabetes y trastornos relacionados
DE602005021501D1 (de) Sulfonamidderivate, ihre herstellung und ihre therapeutische anwendung
DE50207849D1 (de) Substituierte 2-oxy-3,5-dicyano-4-aryl-6-aminopyridine und ihre verwendung
DE60106151D1 (de) Additionshärtbare Silikonelastomermischungen, ihre Herstellung und Verwendung
EE200300311A (et) Ftalasinoon-piperidinoderivaadid, nende kasutamine ja ravim
ATE502035T1 (de) 2-amido-4-phenylthiazol-derivate, ihre herstellung und ihre therapeutische verwendung
ATE459608T1 (de) Oxopiperidinderivate, ihre herstellung und therapeutische verwendung
ATE479437T1 (de) Benzoä4,5üthienoä2,3-düpyrimidin-4-one und ihre therapeutische verwendung
DE60200427D1 (de) Vernetzbare Fluorelastomerzusammensetzungen, ihre Herstellung und Verwendung
ATE231869T1 (de) Pyridopyranoazepinderivate, ihre herstellung und therapeutische verwendung
DE60235547D1 (de) En daraus, deren herstellung und verwendung
ATE312828T1 (de) Acylaminothiazolderivate, deren herstellung und deren therapeutische verwendung
DE60103054D1 (de) Phenyloxazol-1,4-diazabicyclo[3.2.2]nonanderivate, ihre herstellung und ihre therapeutische verwendung
ATE396994T1 (de) 3-phenylpyridoindolderivate, ihre herstellung und verwendung
DE60334632D1 (de) Mechanolumineszenzstoff und dessen herstellung
ATE474840T1 (de) 6-heteroarylpyridoindolon-derivate, ihre herstellung und ihre therapeutische anwendung
DE60144456D1 (de) DibenzoÄb,fÜazepin-Derivate und ihre Herstellung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties